Comerica Bank
CRNX icon

Comerica Bank’s Crinetics Pharmaceuticals CRNX Stock Holding History

Comerica Bank’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$158K Buy
3,396
+2,743
+420% +$122K ﹤0.01% 2411
2025
Q3 		$27.2K Buy
653
+132
+25% +$4.22K ﹤0.01% 3033
2025
Q2 		$15K Sell
521
-476
-48% -$14.7K ﹤0.01% 3126
2025
Q1 		$33.4K Sell
997
-369
-27% -$13.8K ﹤0.01% 2896
2024
Q4 		$69.8K Buy
1,366
+208
+18% +$11.6K ﹤0.01% 2713
2024
Q3 		$59.1K Buy
1,158
+433
+60% +$22.3K ﹤0.01% 2736
2024
Q2 		$32.4K Buy
725
+20
+3% +$924 ﹤0.01% 2873
2024
Q1 		$33K Buy
+705
New +$27.6K ﹤0.01% 2884

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Comerica Bank's CRNX Position: Q4 2025 in Review

Comerica Bank increased its Crinetics Pharmaceuticals (CRNX) stake by 420% in Q4 2025, buying an estimated $122K and bringing the position to 3,396 shares worth $158K. The position accounts for ﹤0.01% of the portfolio, ranked #2411.

Comerica Bank first reported a position in CRNX in Q1 2024 and has held it in 8 quarters since. 240 funds tracked by Wall St. Rank hold CRNX as of Q4 2025.

  • Comerica Bank held 3,396 shares of Crinetics Pharmaceuticals worth $158K as of Q4 2025.
  • Comerica Bank bought 2,743 Crinetics Pharmaceuticals shares in Q4 2025, an estimated $122K.
  • Crinetics Pharmaceuticals made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #2411 holding.
  • Comerica Bank first reported a position in Crinetics Pharmaceuticals in Q1 2024 and has held it in 8 quarters since.
  • 240 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.